Single-cell analyses have emerged as powerful tools for studying cellular heterogeneity and gene regulation. Single-cell chromatin accessibility sequencing (scCAS) is a key technology that enables the ...

In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...

Reeves is an associate professor of pediatrics and epidemiology at the University of Michigan and the principal investigator of the Michigan Sickle Cell Data Collection program. In December 2023, a ...

SAN DIEGO (KGTV) — Having a cell phone nowadays is an essential part of life. It's what we use to communicate with others and stay in the know, but new data shows many of us are paying a lot more than ...

SOUTH SAN FRANCISCO, Calif., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation chimeric antigen receptor (CAR) ...

Patients treated in an outpatient setting who later required admission spent an average of 12.1 days in the hospital, compared to 18.8 days for subsequent admissions among those initially treated in ...

Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...

Muvon Therapeutics has linked its cell therapy to a 60% drop in stress incontinence episode frequency in a small phase 2 trial, leading the biotech to pitch the candidate as a way to reduce reliance ...